B
Biohaven Ltd D
D
BHVN
20.470
USD
-3.16
(-13.37%)
قبل الجلسة
حجم التداول
71
الربح لكل سهم
-7
العائد الربحي
-
P/E
-2
حجم السوق
2,089,270,530
الأخبار المقالات
العنوان: Biohaven Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.